Ipsen US

Fulfilling our commitment to employees and mission to patients in the context of the COVID-19 pandemic

As the COVID-19 pandemic reaches a critical stage in several countries around the world, we at Ipsen remain firm in our commitments to our employees, our communities and patients. Our top priorities are and will remain to ensure the safety of Ipsen’s employees around the world and to focus on business continuity so that we can provide patients with access to our medicines.

Firstly, to ensure health and safety of our employees, we are complying with local health authorities in all of our locations. The Ipsen leadership team is working together closely to give clear directives to all of our collaborators, in line with the most up-to-date recommendations in each location, with many sites shifting to telecommuting.

Secondly, we are working to ensure business continuity at our manufacturing sites, which will continue to operate, so that we can maintain the production and distribution of our medicines for every market we are present in. Our manufacturing sites share one essential objective: ensuring access to our medicines for patients. We are working closely with our national and international suppliers to monitor the provision of goods and services, with the goal of continuing our operations as seamlessly as possible. At this time, we do not anticipate any supply shortage.

Finally, as a Group, we would like to recognize our incredible teams around the world who, despite the difficulties of the last days and weeks, continue to demonstrate their commitment to patients with agility, determination and calm.

If you are a patient and have questions about your Ipsen medication, please contact your physician or you may also contact our Medical Information teams: https://www.ipsenmedicalinformation.com/

COVID-19

About Ipsen US

At Ipsen, we have a clear mission: to improve patients’ lives. We are a dynamic and growing global biopharmaceutical leader focused on innovation and specialty care, with a focus on 3 core areas: oncology, neuroscience, and rare diseases.

 

Read more

About Ipsen US

Corporate Giving

Ipsen seeks to advance scientific knowledge and enhance patient care by funding certain types of requests for healthcare provider or patient education from the medical and scientific community.

Our areas of therapeutic interest fall into 3 categories: oncology, neurosciences, and rare diseases. In particular, we are interested in funding education relating to acromegaly, neuroendocrine tumors, pancreatic cancer, and neuromuscular and movement disorders.

Read more

Corporate Giving

Working at Ipsen US

At Ipsen, we work together to achieve the best solutions for patients. Our culture recognizes and promotes a bold, entrepreneurial spirit among our employees because talented, passionate people are the foundation of our success.

Read more
© Ipsen Biopharmaceuticals, Inc. 2019
NON-US-000672